Literature DB >> 18831896

Cellular distribution of tumour suppressor protein p53 and high-risk human papillomavirus (HPV)-18 E6 fusion protein in wild-type p53 cell lines.

L Sun1, G Zhang, Z Li, T Lei, C Huang, T Song, L Si.   

Abstract

Human papillomaviruses (HPVs) are very important pathogens that can be classified as high- and low-risk types based on the lesions they cause. Mucosal high-risk HPV E6 can target and degrade the tumour suppressor p53, hence it is recognized as the major cause of cervical cancer, however, due to a lack of reliable anti-E6 antibodies, the distribution of high-risk HPV E6 protein remains elusive. The present study, therefore, used a mammalian green fluorescent protein (GFP) expression system to express GFP-18 E6 fusion proteins in wild-type p53 cells, SMMC-7721 and HCT116, in order to trace the location and expression of HPV E6 and p53 protein. Following transfection, expression of GFP-18 E6 was found to be located in the nucleus, and endogenous wild-type p53 was also located there with GFP-18 E6.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18831896     DOI: 10.1177/147323000803600519

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  3 in total

1.  The molecular mechanism and potential role of heat shock-induced p53 protein accumulation.

Authors:  Juqiang Han; Xiaojie Xu; Hongzhen Qin; Anheng Liu; Zhongyi Fan; Lei Kang; Jing Fu; Jiahong Liu; Qinong Ye
Journal:  Mol Cell Biochem       Date:  2013-03-02       Impact factor: 3.396

2.  RNF4 silencing induces cell growth arrest and DNA damage by promoting nuclear targeting of p62 in hepatocellular carcinoma.

Authors:  Bin Lv; Yida Pan; Daisen Hou; Ping Chen; Jun Zhang; Yiwei Chu; Mingqi Li; Yan Zeng; Dongqin Yang; Jie Liu
Journal:  Oncogene       Date:  2022-03-02       Impact factor: 9.867

3.  DNA damage induces down-regulation of Prp19 via impairing Prp19 stability in hepatocellular carcinoma cells.

Authors:  Jie Yin; Yi-An Zhang; Tao-Tao Liu; Ji-Min Zhu; Xi-Zhong Shen
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.